Tilray Brands may see another short squeeze with 15% short interest and strong asset backing.

Tilray Brands (TLRY) is positioned for a potential short squeeze similar to its 2025 rally, supported by 15% short interest and positive technical momentum. The stock trades below tangible book value and has an enterprise value less than its net hard assets, offering a margin of safety. Although not yet GAAP profitable, Tilray targets adjusted EBITDA of $68-75 million by 2027 and holds over $200 million in cash, ensuring liquidity. A full U.S. marijuana rescheduling could trigger a 200-300% price surge, but risks remain if regulatory progress stalls or competition grows.